Abstract:Benzodiazepines and zolpidem are generally prescribed as sedative, hypnotics, anxiolytics or anticonvulsants. These drugs, however, are frequently misused in drug-facilitated crime. Therefore, a rapid and simple liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed for identification and quantification of benzodiazepines, zolpidem and their metabolites in urine using deuterium labeled internal standards (IS). Urine samples (120 μL) mixed with 80 μL of the IS solution were centrifuged. An aliquot (5 μL) of the sample solution was directly injected into the LC-MS/MS system for analysis. The mobile phases consisted of water and acetonitrile containing 2mM ammonium trifluoroacetate and 0.2% acetic acid. The analytical column was a Zorbax SB-C18 (100 mm × 2.1 mm i.d., 3.5 μm, Agilent). The separation and detection of 18 analytes were achieved within 10 min. Calibration curves were linear over the concentration ranges of 0.5-20 ng/mL (zolpidem), 1.0-40 ng/mL (flurazepam and temazepam), 2.5-100 ng/mL (7-aminoclonazepam, 1-hydroxymidazolam, midazolam, flunitrazepam and alprazolam), 5.0-200 ng/mL (zolpidem phenyl-4-carboxylic acid, α-hydroxyalprazolam, oxazepam, nordiazepam, triazolam, diazepam and α-hydroxytriazolam), 10-400 ng/mL (lorazepam and desalkylflurazepam) and 10-100 ng/mL (N-desmethylflunitrazepam) with the coefficients of determination (r(2)) above 0.9971. The dilution integrity of the analytes was examined for supplementation of short linear range. Dilution precision and accuracy were tested using two, four and ten-folds dilutions and they ranged from 3.7 to 14.4% and -12.8 to 12.5%, respectively. The process efficiency for this method was 63.0-104.6%. Intra- and inter-day precisions were less than 11.8% and 9.1%, while intra- and inter-day accuracies were less than -10.0 to 8.2%, respectively. The lower limits of quantification were lower than 10 ng/mL for each analyte. The applicability of the developed method was successfully verified with human urine samples from drug users (n=21). Direct urine sample injection and optimized mobile phases were introduced for simple sample preparation and high-sensitivity with the desired separation.

Restricted Access Magnetic Core-Mesoporous Shell Microspheres with C8-modified Interior Pore-Walls for the Determination of Diazepam in Rat Plasma by LC-MS.

Restricted access magnetic core-mesoporous shell microspheres with C8-modified interior pore walls for the identification of 20(S)-protopanaxadiol metabolites in rat plasma using UPLC-Q-TOF-MS/MS

Synthesis of a novel polydopamine and C18 dual-functionalized magnetic core-shell mesoporous nanocomposite for enrichment and analysis of widely abused illegal drugs in urine samples on site and in the laboratory

Solid Phase Extraction Using Magnetic Core Mesoporous Shell Microspheres with C18-modified Interior Pore-Walls for Residue Analysis of Cephalosporins in Milk by LC–MS/MS

Ultrasound-assisted magnetic dispersive micro-solid-phase extraction based on carbon quantum dots/zeolite imidazolate framework-90/polyvinyl pyrrolidone/Fe3O4 followed by high-performance liquid chromatography with ultraviolet detection for trace analysis of paracetamol and etodolac in human plasma

Direct determination of diazepam and its glucuronide metabolites in human whole blood by μElution solid-phase extraction and liquid chromatography–tandem mass spectrometry

Magnetic solid-phase extraction-based surface-enhanced Raman spectroscopy for label-free therapeutic drug monitoring of carbamazepine and clozapine in human serum

Magnetic solid phase extraction followed by in-situ derivatization with core-shell structured titanium dioxide coated ferriferrous oxide microspheres for determination of alendronate in plasma

Simultaneous Determination of Capilliposide B and Capilliposide C in Rat Plasma by Lc-Ms/Ms and Its Application to A Pk Study

A High-Sensitivity Lc-Ms/Ms Method for the Determination of 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3, 3-Diphenylpropyl Ester Hydrochloride in Rat Plasma and Its Application to A Pharmacokinetics Study

Sensitive, Automatic Method for the Determination of Diazepam and Its Five Metabolites in Human Oral Fluid by Online Solid-Phase Extraction and Liquid Chromatography with Tandem Mass Spectrometry.

Determination of 4-Methylpiperaine-1-carbodithioc Acid 3-Cyano-3,3-diphenylpropyl Ester Hydrochloride in Rats' Plasma by Online-Spe-Hplc-Dad: Application to A Pharmacokinetic Study

Magnetic Solid-Phase Extraction Based on Polydopamine-Coated Magnetic Nanoparticles for Rapid and Sensitive Analysis of Eleven Illicit Drugs and Metabolites in Wastewater with the Aid of UHPLC-MS/MS.

In situ construction of Fe3O4@PDA@Au multi hotspot SERS probe for trace detection of benzodiazepines in serum

Preparation of Carbon-Functionalized Magnetic Graphene/mesoporous Silica Composites for Selective Extraction of Miglitol and Voglibose in Rat Plasma.

[Determination of L-dopa and dopamine in rat brain microdialysate by ultra high performance liquid chromatography-tandem mass spectrometry using stable isotope-coded derivatization coupled with dispersive liquid-liquid microextraction]

Extending the Detection Window of Diazepam by Directly Analyzing Its Glucuronide Metabolites in Human Urine Using Liquid Chromatography–tandem Mass Spectrometry

Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography-tandem mass spectrometry

LC-MS/MS method for the simultaneous determination of icariin and its major metabolites in rat plasma.

Fast Determination of Propofol in Human Plasma Using C18-Functionalized Magnetic Nanomaterials Followed by Supercritical Fluid Chromatography

Preparation and application of nano petal-shaped covalent organic frameworks modified polystyrene-divinylbenzene- glycidylmethacrylate microspheres for the extraction of illicit drugs from wastewater